accountis about EUR2.5 billion. As Sanofi isn't active in Qiagen's main business area, rivals like GlaxoSmithKline PLC (GSK) would seem better positioned for such an acquisition, he added. At 1113 GMT, shares in Qiagen, which provides sample and assay...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to UPDATE: Qiagen Up Amid Talk Sanofi-Aventis May Bid For Co
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account